High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice.
Saved in:
| Title: | High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice. |
|---|---|
| Authors: | Tanguay, J.S.1, Catlow, C.2, Smith, C.1, Barber, J.1, Staffurth, J.2, Kumar, S.1, Palaniappan, N.1, Button, M.1, Mason, M.D.2 |
| Source: | Clinical Oncology. Sep2016, Vol. 28 Issue 9, p611-611. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
